Charlie Hospital Semarang Tbk. vs Surya Biru Murni Acetylene Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp430 (market cap 1.11T, 25.61M 24h volume), while Surya Biru Murni Acetylene Tbk. trades at Rp111 (market cap 101.36B, 1.37M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 11× Surya Biru Murni Acetylene Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.61M versus 1.37M). Which is the better fit depends on your goals.
| RSCH | SBMA | |
|---|---|---|
Market Cap | 1.11T | 101.36B |
Volume | 25.61M | 1.37M |
Lot | 256.07K | 13.68K |
Turnover | 10.76B | 148.72M |
Average Price | 420.16 | 108.68 |
Value | 10.76B | 148.72M |
Indicative Equilibrium Price | 430 | 111 |
Indicative Equilibrium Volume | 1.46K | 1.25K |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Surya Biru Murni Acetylene Tbk (the Company) was established in Balikpapan based on Notarial Deed No. 57 of Mohamad Rasjid Umar, S.H., dated October 25, 1980. The Company started its commercial operations in 1982.
Read more on SBMA →